PubMed ID: 25230402 Author(s): Eadie JA, Gottlieb JL, Ip MS, Blodi BA, Danis RP, Chandra SR, Nork TM, Altaweel MM, Stern-Hogan BS. Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab …
Michael Ip
Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism.
PubMed ID: 23303344 Author(s): Lavine JA, Sang Y, Wang S, Ip MS, Sheibani N. Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism. JAMA Ophthalmol. 2013 Mar;131(3):376-82. doi: 10.1001/jamaophthalmol.2013.1476. PMID 23303344 Journal: Jama Ophthalmology, Volume 131, Issue …
Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology.
PubMed ID: 23062648 Author(s): Kim SJ, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS, Recchia FM. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology. 2013 Feb;120(2):371-8. doi: 10.1016/j.ophtha.2012.07.061. …
Score Study Report 12: Development of venous collaterals in the Score Study.
PubMed ID: 22972448 Author(s): Weinberg DV, Wahle AE, Ip MS, Scott IU, VanVeldhuisen PC, Blodi BA; SCORE Study Investigator Group. Score Study Report 12: Development of venous collaterals in the Score Study. Retina. 2013 Feb;33(2):287-95. …
Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14.
PubMed ID: 23229691 Author(s): Scott IU, Vanveldhuisen PC, Oden NL, Ip MS, Domalpally A, Doft BH, Elman MJ, Blodi BA; SCORE Study Investigator Group. Baseline characteristics and response to treatment of participants with hemiretinal compared …
Diabetic macular edema: therapeutic options.
PubMed ID: 22392532 Author(s): Kulkarni AD, Ip MS. Diabetic macular edema: therapeutic options. Diabetes Ther. 2012 Nov;3(1):1-14. doi: 10.1007/s13300-012-0002-y. Epub 2012 Mar 6. PMID 22392532 Journal: Diabetes Therapy : Research, Treatment And Education Of Diabetes …
Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology.
PubMed ID: 22917890 Author(s): Ho AC, Scott IU, Kim SJ, Brown GC, Brown MM, Ip MS, Recchia FM. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. …
Long-term effects of ranibizumab on diabetic retinopathy severity and progression.
PubMed ID: 22965590 Author(s): Ip MS, Domalpally A, Hopkins JJ, Wong P, Ehrlich JS. Long-term effects of ranibizumab on diabetic retinopathy severity and progression. Arch Ophthalmol. 2012 Sep;130(9):1145-52. doi: 10.1001/archophthalmol.2012.1043. PMID 22965590 Journal: Archives Of …
Diffuse macular edema in niacin-induced maculopathy may resolve with dosage decrease.
PubMed ID: 25390170 Author(s): Freisberg L, Rolle TJ, Ip MS. Diffuse macular edema in niacin-induced maculopathy may resolve with dosage decrease. Retin Cases Brief Rep. 2011 Summer;5(3):227-8. doi: 10.1097/ICB.0b013e3181e180c0. PMID 25390170 Journal: Retinal Cases & …